These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 31543101

  • 1. Outcome of Anticoagulation Therapy of Left Atrial Thrombus or Sludge in Patients With Nonvalvular Atrial Fibrillation or Flutter.
    Yang Y, Du X, Dong J, Ma C.
    Am J Med Sci; 2019 Oct; 358(4):273-278. PubMed ID: 31543101
    [Abstract] [Full Text] [Related]

  • 2. Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter.
    Hussain A, Katz WE, Genuardi MV, Bhonsale A, Jain SK, Kancharla K, Saba S, Shalaby AA, Voigt AH, Wang NC.
    Pacing Clin Electrophysiol; 2019 Sep; 42(9):1183-1190. PubMed ID: 31355470
    [Abstract] [Full Text] [Related]

  • 3. [Effect of non-vitamin K antagonist oral anticoagulants on left atrial or atrial appendage thrombi in patients with nonvalvular atrial fibrillation].
    Cui J, Du X, Wu JH, Jia CQ, Li X, Ning M, Lyu J, Yang Y, Liu XH, Dong JZ, Ma CS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Aug 24; 46(8):606-610. PubMed ID: 30139010
    [Abstract] [Full Text] [Related]

  • 4. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
    Bertaglia E, Anselmino M, Zorzi A, Russo V, Toso E, Peruzza F, Rapacciuolo A, Migliore F, Gaita F, Cucchini U, De Divitiis M, Iliceto S, Stabile G.
    Int J Cardiol; 2017 Dec 15; 249():179-183. PubMed ID: 29121724
    [Abstract] [Full Text] [Related]

  • 5. Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
    Lin C, Quan J, Bao Y, Hua W, Ke M, Zhang N, Jin Q, Xie Y, Wei Y, Ling T, Pan W, Wu L, Xie Y.
    J Cardiovasc Electrophysiol; 2020 Mar 15; 31(3):658-663. PubMed ID: 31975470
    [Abstract] [Full Text] [Related]

  • 6. Left atrial thrombus despite continuous direct oral anticoagulant or warfarin therapy in patients with atrial fibrillation: insights into rates and timing of thrombus resolution.
    Wu MS, Gabriels J, Khan M, Shaban N, D'Amato SA, Liu CF, Markowitz SM, Ip JE, Thomas G, Singh P, Lerman BB, Patel A, Cheung JW.
    J Interv Card Electrophysiol; 2018 Nov 15; 53(2):159-167. PubMed ID: 30078133
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF).
    Lip GY, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B, van Eickels M, Cohen A, X-TRA study and CLOT-AF registry investigators.
    Am Heart J; 2016 Aug 15; 178():126-34. PubMed ID: 27502860
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.
    Lip GYH, Skjøth F, Nielsen PB, Kjældgaard JN, Larsen TB.
    JAMA Cardiol; 2017 Aug 01; 2(8):872-881. PubMed ID: 28614582
    [Abstract] [Full Text] [Related]

  • 11. Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States.
    Coleman CI, Tangirala M, Evers T.
    PLoS One; 2016 Aug 01; 11(6):e0157769. PubMed ID: 27327275
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of Outcomes of Treatment With Oral Anticoagulants in Patients With Atrial Fibrillation and Multiple Chronic Conditions: A Comparative Effectiveness Analysis.
    Mentias A, Shantha G, Chaudhury P, Vaughan Sarrazin MS.
    JAMA Netw Open; 2018 Sep 07; 1(5):e182870. PubMed ID: 30646182
    [Abstract] [Full Text] [Related]

  • 14. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S, Todo K, Koga M, Furui E, Kinoshita N, Kimura K, Yamagami H, Terasaki T, Yoshimura S, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Nagakane Y, Kameda T, Hasegawa Y, Shibuya S, Ito Y, Nakashima T, Takamatsu K, Nishiyama K, Matsuki T, Homma K, Takasugi J, Tokunaga K, Sato S, Kario K, Kitazono T, Toyoda K, SAMURAI Study Investigators.
    Int J Stroke; 2016 Jul 07; 11(5):565-74. PubMed ID: 26927811
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety and Efficacy of Minimally Interrupted Dabigatran vs Uninterrupted Warfarin Therapy in Adults Undergoing Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial.
    Nogami A, Harada T, Sekiguchi Y, Otani R, Yoshida Y, Yoshida K, Nakano Y, Nuruki N, Nakahara S, Goya M, Origasa H, Kihara Y, Hirao K, Aonuma K, ABRIDGE-J (ABlation peRIoperative DabiGatran in use Envisioning in Japan) Investigators.
    JAMA Netw Open; 2019 Apr 05; 2(4):e191994. PubMed ID: 31002317
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.